Navigation Links
Innovotech signs agreement for distribution of its bioFILM PA test in Israel
Date:8/12/2010

Edmonton, Alberta, July 27, 2010 Innovotech Inc. (TSX-V: IOT), a pioneer in the field of biofilm product development, has signed an exclusive distribution agreement with LevPharm Ltd of Israel to market and distribute its bioFILM PA test to hospitals and clinics within Israel.

"We are very excited to enter into this agreement with LevPharm, who recognize the significant impact the bioFILM PA test can have on improving patient care while reducing the cost burden to health care systems," said Ken Boutilier, President and CEO of Innovotech Inc. "The partnership with LevPharm illustrates their understanding of the importance of technologies for biofilm management, and further demonstrates Israel's leadership in embracing innovative products and solutions to enhance their health care system."

The current market capacity in Israel for acute infection treatment alone is estimated to be over 3,000 bioFILM PA tests per year.

bioFILM PA is the first diagnostic test to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based Pseudomonas aeruginosa infections.

Pseudomonas aeruginosa is a common bacterium responsible for many hospital acquired infections including ventilator-associated pneumonia and those found in patients with burns and wounds. It is also one of the major causes of lung infections in individuals with Cystic Fibrosis.

Over eighty percent of microbial infections in the body are caused by organisms in a biofilm state. Biofilm infections are known to be up to 4,000 times more resistant to antibiotics than the same organism in a free-floating state, which demonstrates why it is so critical to identify effective treatments early, such as through the bioFILM PA test.


'/>"/>

Contact: Ken Boutilier
ken.boutilier@innovotech.ca
780-448-0585
Innovotech Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. Innovotech receives funding to advance environmentally friendly agricultural crop protection product
2. Syngenta Crop Protection Canada announces seed treatment project with Innovotech
3. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
4. Signs of reversal of Arctic cooling in some areas
5. Lake sturgeon have genes from parasite, signs of human STD
6. Phosphorous in sodas and processed foods accelerates signs of aging say Harvard scientists
7. Moffitt Cancer Center signs licensing agreement with Proteacel, LLC
8. Springer signs publishing agreement with ISOBM
9. Springer signs agreement with British Society of Research on Ageing
10. Copying mother natures designs
11. Plate-eating good: Université de Montréal professor designs edible tableware
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... Longmont, Colorado (PRWEB) , ... June 21, 2017 ... ... the RTP regional office in North Carolina, and engages Timothy Reinhardt to manage ... years of quality leadership at Pfizer Inc, with his most recent role as ...
(Date:6/22/2017)... ... 22, 2017 , ... Ovation Fertility supports the American Medical ... new hope for prospective parents who are challenged with costs of treatment. AMA ... Health Organization’s designation in hopes of changing the way health insurers, governments and ...
(Date:6/22/2017)... ... 2017 , ... The first human cell line HeLa, established in 1951, has ... cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination and ... and is associated with dramatic consequences for research. , In this educational webinar, ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext , ... directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the recommendations ... and other high-ranking representatives from 35 higher education institutions across the state over ...
Breaking Biology Technology: